We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.99%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$110B
AUM Growth
+$11.3B
(+11%)
Cap. Flow
+$8.89B
Cap. Flow
% of AUM
8.09%
Top 10 Holdings %
Top 10 Hldgs %
35.27%
Holding
3,643
New
809
Increased
972
Reduced
1,047
Closed
744
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.35B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$2.85B |
| 3 |
Eli Lilly
LLY
|
+$999M |
| 4 |
Coca-Cola
KO
|
+$685M |
| 5 |
Broadcom
AVGO
|
+$616M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.38B |
| 2 |
Apple
AAPL
|
+$1.12B |
| 3 |
Netflix
NFLX
|
+$678M |
| 4 |
Boston Scientific
BSX
|
+$671M |
| 5 |
Cencora
COR
|
+$627M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Consumer Discretionary | 12.77% |
| 3 | Healthcare | 10.45% |
| 4 | Financials | 7.74% |
| 5 | Communication Services | 5.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FLOC
1126
Flowco Holdings
FLOC
$843M
| $5.1M | ﹤0.01% |
272,329
-93,418
| -26% | -$1.56M |
|
1127
Achieve Life Sciences
ACHV
$626M
| $5.07M | ﹤0.01% |
1,019,281
+244,428
| +32% | +$1.07M |
|
1128
Varonis Systems
VRNS
$5.25B
| $5.06M | ﹤0.01% |
154,364
+132,992
| +622% | +$5.58M |
|
1129
SELLAS Life Sciences
SLS
$2.23B
| $5.05M | ﹤0.01% |
1,340,668
-1,017,331
| -43% | -$1.98M |
|
1130
Aurora
AUR
$11.7B
| $5.03M | ﹤0.01% |
1,309,482
-862,412
| -40% | -$3.95M |
|
1131
Liquidia Corp
LQDA
$7.67B
| $5.02M | ﹤0.01% |
145,639
-186,650
| -56% | -$5.31M |
|
1132
Viatris
VTRS
$20.1B
| $5.02M | ﹤0.01% |
402,859
+86,186
| +27% | +$930K |
|
|
NAVN
1133
Navan Inc
NAVN
$5.9B
| $5.01M | ﹤0.01% |
+293,491
| New | +$4.66M |
|
1134
Weyerhaeuser
WY
$17.3B
| $5.01M | ﹤0.01% |
+211,530
| New | +$4.89M |
|
1135
Red Violet
RDVT
$859M
| $5.01M | ﹤0.01% |
87,906
-23,194
| -21% | -$1.26M |
|
1136
Coca-Cola Consolidated
COKE
$12.3B
| $5M | ﹤0.01% |
32,624
-77,560
| -70% | -$11.4M |
|
1137
NB Bancorp
NBBK
$983M
| $4.98M | ﹤0.01% |
251,512
-25,588
| -9% | -$487K |
|
|
1138
CALL
Broadcom
AVGO
$1.82T
| $4.98M | ﹤0.01% |
14,400
-54,000
| -79% | -$19.3M |
|
1139
PUT
CrowdStrike
CRWD
$187B
| $4.97M | ﹤0.01% |
42,400
-120,800
| -74% | -$15.4M |
|
1140
Dillards
DDS
$8.87B
| $4.96M | ﹤0.01% |
8,187
+3,896
| +91% | +$2.45M |
|
1141
Buckle
BKE
$2.19B
| $4.94M | ﹤0.01% |
92,527
+39,499
| +74% | +$2.2M |
|
1142
FreightCar America
RAIL
$275M
| $4.94M | ﹤0.01% |
446,420
+214,397
| +92% | +$1.97M |
|
1143
Axogen
AXGN
$2.1B
| $4.94M | ﹤0.01% |
150,790
-36,518
| -19% | -$898K |
|
1144
CytomX Therapeutics
CTMX
$705M
| $4.93M | ﹤0.01% |
1,156,936
+51,943
| +5% | +$197K |
|
1145
Lattice Semiconductor
LSCC
$17.6B
| $4.86M | ﹤0.01% |
66,100
+16,761
| +34% | +$1.19M |
|
1146
Commault Systems
CVLT
$5.89B
| $4.85M | ﹤0.01% |
+38,711
| New | +$5.45M |
|
1147
Trex
TREX
$4.51B
| $4.85M | ﹤0.01% |
138,257
+5,768
| +4% | +$233K |
|
1148
Teck Resources
TECK
$29.5B
| $4.85M | ﹤0.01% |
101,194
-961,016
| -90% | -$41.6M |
|
1149
Aviat Networks
AVNW
$262M
| $4.84M | ﹤0.01% |
226,580
+132,262
| +140% | +$2.95M |
|
1150
Marcus Corp
MCS
$732M
| $4.83M | ﹤0.01% |
311,291
-29,195
| -9% | -$434K |
|
Similar funds
Marshall Wace's Q4 2025 Portfolio in Review
As of Q4 2025, Marshall Wace held 3,643 positions worth $110B, up 11% from $98.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Marshall Wace deployed $8.89B of net new capital in Q4 2025, opening 809 new positions and adding to 972 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Microsoft, an estimated $1.38B trimmed.
- Marshall Wace's largest Q4 2025 buy was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $3.35B increase.
- Marshall Wace's biggest Q4 2025 reduction was Microsoft, cutting an estimated $1.38B.
- Marshall Wace fully exited Ares Management in Q4 2025, selling an estimated $146M.
- Marshall Wace's ten largest holdings make up 35% of its $110B portfolio in Q4 2025.
- Marshall Wace opened 809 new positions and closed 744 in Q4 2025.
- Marshall Wace's portfolio value rose 11% quarter-over-quarter to $110B.
Based on Marshall Wace's 13F filing for Q4 2025, filed 13 Feb 2026.